An herbal supplement containing Ma Huang-Guarana for weight loss: A randomized, double-blind trial

International Journal of Obesity

Volumn 25, Issue 3, 2001, Pages 316-324

  Boozer, C N ^a   Nasser, J A ^a   Heymsfield, S B ^a   Wang, V ^a   Chen, G ^a   Solomon, J L ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Alternative medicine; Clinical trial; Ephedra; Herbal medicine; Obesity

Indexed keywords

CAFFEINE; EPHEDRINE; GUARANA; HERBACEOUS AGENT; PLACEBO; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ALTERNATIVE MEDICINE; ANTHROPOMETRY; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EPHEDRA; FEMALE; HEADACHE; HIP; HUMAN; INSOMNIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLISM; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; TREATMENT OUTCOME; WEIGHT REDUCTION; XEROSTOMIA;

ADULT; ANTHROPOMETRY; BLOOD PRESSURE; CAFFEINE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUGS, CHINESE HERBAL; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; OBESITY; THEOBROMINE; THEOPHYLLINE; TRIGLYCERIDES; WEIGHT LOSS;

EPHEDRA; PAULLINIA CUPANA;

EID: 0035098157     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801539     Document Type: Article

References (40)

1. A comparative study of synthetic and natural ephedrines
2. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991
3. Waist circumference reduction and cardiovascular benefits during weight loss in women
4. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent. A randomized clinical trial
5. Pharmacokinetics and cardiovascular effects of ma-huang (Ephedra sinica) in normotensive adults
6. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double-blind trial
7. Chiral gas chromatographic Determination of ephedrine-type alkaloids in dietary supplements containing Ma Huang
8. Ephedrine, a potential slimming drug, directly stimulates thermogenesis in brown adipocytes via beta-adrenoreceptors
9. The thermogenic properties of ephedrine/methylxanthine mixtures: Human studies
10. Reversal of obesity in the genetically obese fa/fa Zucker rat with an ephedrine/methylxanthines thermogenic mixture
11. The thermogenic properties of ephedrine/methylxanthine mixtures: Animal studies
12. Safety and efficacy of long-term treatment with ephedrine, caffeine, and ephedrine/caffeine mixture
13. Ephedrine as an anorectic: The story of the 'Elsinore pill'
14. Long term pharmacotherapy in the management of obesity
15. Short-term medical benefits and adverse effects of weight loss
16. A new air displacement method for determination of human body composition
17. Body composition from fluid spaces and density: Analysis of methods
18. Factors that influence the outcome of placebo-controlled antidepressant clinical trials
19. Thermogenic, metabolic, and cardiovascular effects of a sympathomimietic agent, ephedrine
20. Ephedrine, caffeine and aspirin: Safety and efficacy for treatment of human obesity
21. Thermogenic synergism between ephedrine and caffeine in healthy volunteers: A double blind placebo-controlled study
22. Energy expenditure, body composition, and glucose metabolism in lean and obese rhesus monkeys treated with ephedrine and caffeine
23. Ephedrine, xanthines and prostaglandin-inhibitors; actions and interactions in the stimulation of thermogenesis
24. Clinical aspects of ephedrine in the treatment of obesity
25. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice
26. Is Letigen contraindicated in hypertension? A double-blind, placebo controlled multipractice study of letigen administered to normotensive and adequately treated patients with hypersensitivity
27. Pharmaceutical cost savings of treating obesity with weight loss medications
28. Editorial
29. Effect of Guarana on exercise in normal and ephedrine-induced glycogenolytic mice
30. Unsafe and potentially safe herbal therapies
31. Adverse events associated with ephedrine-containing products - Texas, December 1993-September 1995
32. Sibutramine produces dose-related weight loss
33. Efficacy and tolerability of sibutramine in obese patients: A dose-ranging study
34. Sibutramine in weight control: A dose-ranging, efficacy study
35. A comparison of sibutramine and dexfenfluramine in the treatment of obesity
36. Thermogenic effects of sibutramine in humans